cuprizone has been researched along with Wallerian Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bando, Y; Ito, S; Kashiwayanagi, M; Takakusaki, K; Terayama, R; Yoshida, S | 1 |
| Gudi, V; Hildebrandt, H; Koutsoudaki, PN; Moharregh-Khiabani, D; Skripuletz, T; Stangel, M; Trebst, C | 1 |
2 other study(ies) available for cuprizone and Wallerian Degeneration
| Article | Year |
|---|---|
Differential changes in axonal conduction following CNS demyelination in two mouse models.
Topics: Animals; Axons; Central Nervous System; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Electric Stimulation; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Neurologic Mutants; Motor Cortex; Myelin Basic Protein; Nerve Fibers, Myelinated; Neural Conduction; Neural Pathways; Reaction Time; Wallerian Degeneration | 2008 |
Demyelination of the hippocampus is prominent in the cuprizone model.
Topics: Animals; Astrocytes; Biomarkers; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gliosis; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Fibers, Myelinated; Nerve Tissue Proteins; Neurotoxins; Wallerian Degeneration | 2009 |